Reports
Global Speciality Generics Market: By Route of Administration: Injectable, Oral, Others; By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Others; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Speciality Generics Market Outlook
The global speciality generics market size reached a value of almost USD 45.6 billion in the year 2020. The industry is further expected to grow at a CAGR of 12% between 2021 and 2026 to reach a value of almost USD 90 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global speciality generics market is driven by the research and development activities, globally. North America is the leading regional market for speciality generics, bolstered by the increasing cases of chronic and complex health conditions such as cancer, epilepsy, HIV, autoimmune diseases, Hepatitis, multiple sclerosis, and rheumatoid arthritis in the region. Speciality generics offer a cost-effective alternative to the branded versions as they do not require costly development and marketing costs, which is further aiding the industry growth.
Market Segmentation
Speciality generics are referred to as off-patented drugs, which are used to treat chronic or complex health conditions. These drugs require special handling, monitoring, and usually require prior authorisation to order them. Currently, speciality generics are gaining enormous popularity as they are utilised to treat rare chronic diseases like HIV AIDS, cancer, rheumatoid arthritis, and haemophilia.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The speciality generics market is segmented on the basis of route of administration:
- Injectable
- Oral
- Others
Currently, injectables dominate the market across the globe.
On the basis of indication, the speciality generics market is categorised into:
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Others
Among all of these, oncology accounts for the majority of the global market share.
On the basis of distribution channel, the industry is divided into:
- Retail Pharmacies
- Speciality Pharmacies
- Hospital Pharmacies
- Others
Presently, the products are majorly distributed through the medium of speciality pharmacies.
The report also covers the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The global speciality generics market is driven by the supporting policies and regulations by the governments of several countries to help in the production of speciality generics. In addition to this, speciality generic drugs are less expensive to produce and manufacture as compared to newly patented drugs, as they are not required to go through any clinical trials and approval prior to entering the industry. On account of this, these products offer low risk and high margins in comparison to newly patented drugs, which generally take about 3- 4 years in product development and approval.
The industry is further aided by the rising research and development (R&D) activities to create new and innovative formulations that offer more efficient and cost-effective options as compared to their branded counterparts. Moreover, many companies are expanding their capacities as they are getting involved with mergers and acquisitions (M&A). For instance, Alvogen, a pharmaceutical company, acquired County Line Pharmaceuticals, a company committed to the formulation of speciality generics.
Competitive Landscape
The report gives a detailed analysis of the following key players in the global speciality generics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Mallinckrodt plc
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd
- Apotex Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Route of Administration, Indication, Distribution Channel, Region |
| Breakup by Route of Administration | Injectable, Oral, Others |
| Breakup by Indication | Oncology, Autoimmune Diseases, Infectious Diseases, Others |
| Breakup by Distribution Channel | Retail Pharmacies, Speciality Pharmacies, Hospital Pharmacies, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, Apotex Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Speciality Generics Market Analysis
8.1 Key Industry Highlights
8.2 Global Speciality Generics Historical Market (2018-2022)
8.3 Global Speciality Generics Market Forecast (2023-2028)
8.4 Global Speciality Generics Market by Route of Administration
8.4.1 Injectable
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Oral
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Others
8.5 Global Speciality Generics Market by Indication
8.5.1 Oncology
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Autoimmune Diseases
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Infectious Diseases
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Speciality Generics Market by Distribution Channel
8.6.1 Retail Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Speciality Pharmacies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Hospital Pharmacies
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Speciality Generics Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Speciality Generics Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Speciality Generics Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Speciality Generics Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Speciality Generics Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Speciality Generics Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.3.1 Teva Pharmaceutical Industries Ltd.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Demographic Reach and Achievements
16.3.1.4 Financial Summary
16.3.1.5 Certifications
16.3.2 Mylan N.V.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Demographic Reach and Achievements
16.3.2.4 Financial Summary
16.3.2.5 Certifications
16.3.3 Mallinckrodt plc
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Demographic Reach and Achievements
16.3.3.4 Financial Summary
16.3.3.5 Certifications
16.3.4 Pfizer, Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Demographic Reach and Achievements
16.3.4.4 Financial Summary
16.3.4.5 Certifications
16.3.5 Sun Pharmaceutical Industries Ltd
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Demographic Reach and Achievements
16.3.5.4 Financial Summary
16.3.5.5 Certifications
16.3.6 Apotex Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Demographic Reach and Achievements
16.3.6.4 Financial Summary
16.3.6.5 Certifications
16.3.7 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Speciality Generics Market: Key Industry Highlights, 2018 and 2028
2. Global Speciality Generics Historical Market: Breakup by Route of Administration (USD Billion), 2018-2022
3. Global Speciality Generics Market Forecast: Breakup by Route of Administration (USD Billion), 2023-2028
4. Global Speciality Generics Historical Market: Breakup by Indication (USD Billion), 2018-2022
5. Global Speciality Generics Market Forecast: Breakup by Indication (USD Billion), 2023-2028
6. Global Speciality Generics Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2022
7. Global Speciality Generics Market Forecast: Breakup by Distribution Channel (USD Billion), 2023-2028
8. Global Speciality Generics Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Speciality Generics Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Speciality Generics Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Speciality Generics Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Speciality Generics Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Speciality Generics Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Speciality Generics Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Speciality Generics Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Speciality Generics Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Speciality Generics Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Speciality Generics Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Speciality Generics Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Speciality Generics Market Structure
Key Questions Answered in the Report
The global speciality generics market reached a value of USD 45.6 billion in 2020.
The market is projected to grow at a CAGR of nearly 12% in the forecast period of 2023-2028.
The market is estimated to reach a value of about USD 90 billion by 2026.
The major drivers of the industry include the rising disposable incomes, increasing population, research and development activities, and the rising competition among key players.
The rising supporting policies and regulations by the governments are expected to be the key trends guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.
Injectables is the dominant route of administration of the product in the market.
Oncology is the leading indication of the product in the industry.
The speciality pharmacies segment accounts for the largest market share, among other distribution channels in the industry.
The leading players in the market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Inc., among others.
Analyst Review
The global speciality generics market attained a value of USD 45.6 billion in 2020, driven by the rising research and development activities. Aided by the growing pharmaceuticals sector, the industry is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 12%. The industry is projected to reach USD 90 billion by 2026.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its route of administration, the industry can be segmented into injectable and oral, among others, with injectable accounting for the largest market share. By indication, oncology leads the industry. On the basis of distribution channel, the speciality pharmacy segment accounts for the largest share in the global industry. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER